Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000529417 | SCV000646560 | likely benign | Colorectal cancer, susceptibility to, 10 | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722500 | SCV000718576 | likely benign | not provided | 2019-02-19 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000529417 | SCV000786269 | likely benign | Colorectal cancer, susceptibility to, 10 | 2018-04-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456167 | SCV002737199 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003900195 | SCV004713765 | likely benign | POLD1-related condition | 2022-10-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |